Insider filing · RAPP
Krishnaswamy Yeleswaram
Chief Development Officer
profile →
Rapport Therapeutics, Inc.
RAPP · Healthcare · 32 filings in 24 months
ticker →
Krishnaswamy Yeleswaram sold $809K of Rapport Therapeutics (RAPP)
Executed Apr 17, disclosed Apr 21, 4 days later.
Value, as filed
$809K
20,225 sh × $39.99
Executed
Apr 17
the trade date, as filed
Disclosed
Apr 21
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KYKrishnaswamy Yeleswaram (Chief Development Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.5M of RAPP (50,160 sh across 3 lots, as filed), executed Aug 24.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Krishnaswamy Yeleswaram in RAPP
RAPPSALE
Rapport Therapeutics, Inc.
$2.5M50,160 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:00 PM ET RAPPSALE Rapport Therapeutics, Inc. $678K
19,365 sh across 2 lots
Exec Apr 13
Filed Apr 14 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $303K
10,115 sh × $29.99
Exec Mar 25
Filed Mar 26 · 5:30 PM ET